Sirtex, SingHealth to explore nanoparticles in treating cancer

12/6/2012 | Genetic Engineering & Biotechnology News

Sirtex Medical and SingHealth have entered a deal to develop the use of carbon-cage nanoparticles in treating cancer. The technology is based on Technegas, which is used in nuclear medicine as an inhalable aerosol of carbon-cage nanoparticles for detecting blood clots in the lungs. The first research initiative under the partnership will explore the technology as a treatment for advanced ovarian cancer that has metastasized in the abdomen and pelvic region.

View Full Article in:

Genetic Engineering & Biotechnology News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY